Leadenhall UCITS ILS Fund B USD Acc

Register to Unlock Ratings
Performance History31/03/2024
Growth of 1,000 (GBP) Advanced Graph
Leadenhall UCITS ILS Fund B USD Acc
Fund3.24.613.29.34.7
+/-Cat-----
+/-B’mrk-----
 
Key Stats
NAV
19/04/2024
 USD 150.34
Day Change 0.29%
Morningstar Category™ Other Bond
ISIN IE00BYTQ6J71
Fund Size (Mil)
30/07/2021
 USD 562.10
Share Class Size (Mil)
04/09/2020
 USD 2.06
Max Initial Charge -
Ongoing Charge
20/02/2023
  0.45%
Investment Objective: Leadenhall UCITS ILS Fund B USD Acc
The Fund’s objective is to achieve absolute return for investors.The Fund will invest primarily in catastrophe bonds and other securities, payments on which are linked to insurance payouts as a result of natural or non-natural catastrophic events. These include earthquakes and windstorms, and other mortality and catastrophe-related events.The Fund may also invest in liquid assets and retain a proportion of its assets in cash and deposits.The Fund may use futures and options relating to weather or insurance indices for investment purposes and for the purpose of hedging risks.
Returns
Trailing Returns (GBP)19/04/2024
YTD7.27
3 Years Annualised12.03
5 Years Annualised8.03
10 Years Annualised-
12 Month Yield 0.00
Management
Manager Name
Start Date
-
-
Inception Date
21/12/2015
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
Swiss Re Total Return Cat Bond-
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthNot Specific
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  Leadenhall UCITS ILS Fund B USD Acc-
Top 5 Holdings%
No Data Available
Fixed Income
Effective Maturity-
Effective Duration-
Morningstar Style Box®
Fixed Income Style
Asset Allocation
  % Long% Short% Net Assets
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures